Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jazz Pharma Plc (NQ: JAZZ ) 101.12 +0.55 (+0.55%) Streaming Delayed Price Updated: 11:50 AM EDT, Jul 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Jazz Pharma Plc < Previous 1 2 ... 5 6 7 8 9 10 11 12 Next > EXCLUSIVE: Aurora Cannabis CEO 'Absolutely Confident' Company Will Be EBITDA-Positive By Year's End April 20, 2022 Miguel Martin, CEO of Aurora Cannabis Inc (NASDAQ: ACB), discussed growing Aurora into the leader of the international medical cannabis market at the Benzinga Cannabis Capital Conference on Wednesday. Via Benzinga Axsome Therapeutics Stock Rockets As Its First FDA Approval Looks Imminent April 19, 2022 The company agreed to the FDA's post-marketing requirements for a depression drug. Via Investor's Business Daily Avicanna's Cannabinoid Drugs To Reach Brazil Via Its First 'Big Pharma' Deal April 13, 2022 Via Benzinga Syros' CDK12 Inhibitor Shows Anti Tumor Activity In Preclinical Studies April 11, 2022 Syros Pharmaceuticals Inc (NASDAQ: SYRS) Via Benzinga Werewolf Therapeutics Shares Jump On Cancer Product Pact With Jazz Pharma April 07, 2022 Via Benzinga Expert Ratings For Jazz Pharmaceuticals April 06, 2022 Over the past 3 months, 4 analysts have published their opinion on Jazz Pharmaceuticals (NASDAQ:JAZZ) stock. These analysts are typically employed by large Wall Street banks and tasked with... Via Benzinga Earnings Scheduled For March 1, 2022 March 01, 2022 Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 April 06, 2022 Upgrades Via Benzinga 10 Biggest Price Target Changes For Wednesday April 06, 2022 Raymond James reduced the price target on Intercontinental Exchange, Inc. (NYSE: ICE) from $161 to $157. Intercontinental Exchange shares rose 0.2% to $130.79 in pre-market trading. Via Benzinga Why Axsome Therapeutics Stock Is Trading Higher March 28, 2022 Axsome Therapeutics Inc (NASDAQ: AXSM) is trading higher Monday morning after the company announced it will acquire Sunosi from Jazz Therapeutics PLC (NASDAQ: JAZZ). Via Benzinga Axsome Acquires Sleep Disorder Drug From Jazz Pharma, Expanding Its Neuroscience Portfolio March 28, 2022 Axsome Therapeutics Inc (NASDAQ: AXSM) has Via Benzinga The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO March 25, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga Jazz Pharmaceuticals's Return On Capital Employed Insights March 03, 2022 According to data from Benzinga Pro, during Q4, Jazz Pharmaceuticals's (NASDAQ:JAZZ) reported sales totaled $896.73 million. Despite a 33.09% increase in earnings, the company... Via Benzinga Court Dismisses Canopy's Cannabis Patent Infringement Lawsuit Against Jazz's GW Pharma March 03, 2022 The U.S. District Court for the Western District of Texas dismissed a lawsuit filed by Canadian cannabis giant C... Via Benzinga Expert Ratings For Jazz Pharmaceuticals March 02, 2022 Jazz Pharmaceuticals (NASDAQ:JAZZ) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... Via Benzinga Jazz Pharmaceuticals Announces Full Year And 4Q 2021 Financial Results March 01, 2022 Jazz Pharmaceuticals plc (NASDAQ:JAZZ), a global biopharma... Via Benzinga Jazz Pharmaceuticals: Q4 Earnings Insights March 01, 2022 Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... Via Benzinga The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution March 01, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine... Via Benzinga The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight February 27, 2022 Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... Via Benzinga This Company's 18-Month CBD Stability Achievement Could Hint Towards Expansion Goals As It Plans To Release First Commercial UST System In 2022 February 10, 2022 Photo by Kindel Media from Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga Does This Company's Recent CBD Breakthrough Earn It A Spot In The Guinness World Records? February 04, 2022 Photo by CBD Infos on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga New Psychedelics ETF Launches On NYSE Arca February 02, 2022 Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)... Via Benzinga The "Cannabis 50" List For 2021 Is Out, Is Your Favorite Company On It? January 28, 2022 MGO (Macias Gini and O’Connell LLP), a leader in accounting, tax, audit and advisory solutions for the cannabis and hemp industries has released its 3rd annual “Cannabis 50” list. Via Benzinga Jim Cramer Shares His Thoughts On ArcBest, Ulta Beauty And More January 27, 2022 On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes ArcBest Corporation (NASDAQ: Via Benzinga Zogenix Nabs $1.9 Billion Takeover As Epilepsy Drug Piques UCB Interest January 19, 2022 The deal includes a CVS tied to Fintepla's next potential approval. Via Investor's Business Daily Report: Global Cannabis Beverages Market Expected To Reach $2B By 2026 January 14, 2022 As the COVID-19 pandemic continues, the global market for cannabis beverages estimated at $799.8 million 2020, is projected to reach a revised... Via Benzinga 60 Biggest Movers From Yesterday January 11, 2022 Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company... Via Benzinga A Peek Into The Markets: US Stock Futures Up Ahead Of Manufacturing Report January 04, 2022 Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones and S&P 500 closed at fresh highs on the first trading day of new year.... Via Benzinga 5 Stocks To Watch For January 4, 2022 January 04, 2022 Some of the stocks that may grab investor focus today are: Wall Street expects SMART Global Holdings, Inc. (NASDAQ: SGH) to report quarterly earnings at $2.00 per share on... Via Benzinga Ten Biggest Weed Stories Of 2021: Big Pharma, Delta-8, Tech, Silicon Valley, MSOs, Politics And More January 03, 2022 This article was originally published on WeedWeek and appears here with... Via Benzinga < Previous 1 2 ... 5 6 7 8 9 10 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.